HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fragrance Creators Association Highlights Industry’s Role In Answering COVID-19 Needs

Executive Summary

The US fragrance industry advocate is promoting the efforts of its members to maintain supplies of cleaning and sanitizing products amid the COVID-19 pandemic. Across the personal- and home-care sectors, companies are going to extra lengths to put disinfectants in the hands of those in need.  

You may also be interested in...



Fragrance Creators Advocacy Off To Brisk Start On Capitol Hill

The trade association’s foremost priorities in 2021 include “advocating for science-based regulations and education and promoting newer, greener chemistry and technology.” 

Fragrance Community Pushes For Tariff Relief In Name Of COVID19 Fight

Fragrance industry advocates say 10% to 15% of raw materials used in fragrance come from China, many subject to tariffs imposed in the US-China trade war. The COVID-19 pandemic highlights the need for tariff relief, as fragrance plays a vital role in germ-killing and personal hygiene products in high demand, commenters tell the USTR.

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel